SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT)
announced today a proposed offering of senior unsecured notes (the
“New Notes”) (the “Debt Offering”), a cash tender offer for any and
all of its 4.600% Senior Notes due 2026 (the “2026 Notes”) (the
“Tender Offer”) and that it will redeem all its outstanding 7.00%
Senior Notes due 2025 (the “2025 Notes”) (the “Redemption”).
Scott Egan, CEO of SiriusPoint, said, “2023 was
a turnaround year for SiriusPoint as we executed against our
strategic priorities to simplify the business, reduce volatility,
and deliver a double-digit return on equity. We achieved a record
$339 million dollar net income to common shareholders in 2023, a
$742 million dollar improvement year on year and a 16.2% annualized
return on equity. As we transition to the next phase of our
journey, we are focused on improving the quality of the balance
sheet further. The Debt Offering, Tender Offer and Redemption are
important steps to optimize our capital structure and lower our
debt leverage. A completion of these transactions would make our
already strong balance sheet even stronger and will mark a
significant stride forward for our company.”
New Notes Debt Offering
SiriusPoint intends to offer, subject to market
and other conditions, senior notes in a public offering.
SiriusPoint intends to use the net proceeds from
the Debt Offering, together with available cash, to fund the
purchase of the 2026 Notes validly tendered and accepted for
purchase in the Tender Offer. SiriusPoint intends to use any
remaining proceeds for general corporate purposes, which may
include the redemption, repurchase or repayment at maturity of
indebtedness (including the Redemption).
BMO Capital Markets Corp., HSBC Securities (USA)
Inc., Jefferies LLC and J.P. Morgan Securities LLC will act as
joint book-running managers of the Debt Offering.
The Debt Offering is being made pursuant to an
effective shelf registration statement on Form S-3 and by means of
a prospectus and related preliminary prospectus supplement filed
with the Securities and Exchange Commission (the “SEC”). Before you
invest, you should read the prospectus and the related preliminary
prospectus supplement and the documents incorporated by reference
therein that SiriusPoint has filed with the SEC for more complete
information about SiriusPoint and the Debt Offering.
Copies of the prospectus and related preliminary
prospectus supplement may be obtained on the SEC’s website at
www.sec.gov. Alternatively, you may request them by contacting BMO
Capital Markets Corp. at (866) 864-7760, HSBC Securities (USA) Inc.
at (866) 811-8049, Jefferies LLC at (877) 877-0696 and J.P. Morgan
Securities LLC at (212) 834-4533.
Tender Offer and Consent
Solicitation
SiriusPoint has commenced the Tender Offer for
any and all of the outstanding $400 million aggregate principal
amount of its 2026 Notes.
In connection with the Tender Offer, SiriusPoint
is also soliciting consents (the “Consent Solicitation”) from the
holders of the 2026 Notes for the adoption of a proposed amendment
(the “Proposed Amendment”) to the indenture governing the 2026
Notes (the “2026 Indenture”) to reduce the minimum required notice
period for the redemption of the 2026 Notes from 30 days to three
business days.
The Tender Offer and Consent Solicitation are
being made pursuant to an Offer to Purchase and Consent
Solicitation Statement, dated March 21, 2024 (as may be amended or
supplemented from time to time, the “Offer to Purchase”).
Holders who tender 2026 Notes must also consent
to the Proposed Amendment. Holders of 2026 Notes may not deliver
consents to the Proposed Amendment without validly tendering the
2026 Notes in the Tender Offer and may not revoke their consents
without withdrawing the previously tendered 2026 Notes to which
they relate. The Proposed Amendment will be set forth in a
supplemental indenture relating to the 2026 Notes and is described
in more detail in the Offer to Purchase. Adoption of the Proposed
Amendment requires the delivery of consents by holders of a
majority of the aggregate outstanding principal amount of 2026
Notes.
Certain information regarding the 2026 Notes and
the terms of the Tender Offer and the Consent Solicitation is
summarized in the table below.
Title of Security |
|
CUSIP Numbers and ISIN (144A / Reg S) |
|
Principal Amount Outstanding |
|
Reference Treasury
Security(1) |
|
Bloomberg Reference Page(1) |
|
Fixed Spread (basis points) |
|
Early Tender Payment (per
$1,000)(2) |
4.600% Senior Notes due 2026 |
|
82968FAA2 / G8201F AA7US82968FAA21 / USG8201FAA78 |
|
$400,000,000 |
|
1.875% UST due July 31, 2026 |
|
FIT5 |
|
+45 |
|
$50 |
_________
(1) The reference yield (the
“Reference Yield”) will be calculated based on the bid-side price
of the Reference Treasury Security as quoted on the Bloomberg
Reference Page at 10:00 a.m., New York City time, on April 4,
2024.
(2) The total consideration offered
per $1,000 principal amount of 2026 Notes validly tendered and
accepted for purchase prior to the Early Expiration Time (as
defined below) pursuant to the Tender Offer (the “Total
Consideration”) will be determined by the Dealer Managers (as
defined below) in the manner described in the Offer to Purchase and
will be equal to the greater of (x) the sum of the present value of
the remaining payments of principal and interest on the 2026 Notes
from the settlement date to (but excluding) August 1, 2026 (three
months prior to the maturity date of the 2026 Notes), at a discount
rate equal to the sum of the Fixed Spread plus the Reference Yield
and (y) $1,000.
The Total Consideration includes an early tender
payment of $50 for each $1,000 principal amount of 2026 Notes to
holders who validly tender 2026 Notes and deliver consents by a
deadline of 5:00 p.m., New York City time, on April 4,
2024, unless extended or earlier terminated by SiriusPoint (the
“Early Expiration Time”). The 2026 Notes tendered may be withdrawn
and consents for the Proposed Amendment delivered may be revoked at
any time prior to the Early Expiration Time, but not thereafter,
except as may be required by applicable law. Those who validly
tender 2026 Notes and deliver consents before the Early Expiration
Time will receive the Total Consideration for each $1,000 principal
amount of accepted 2026 Notes. Those who validly tender 2026 Notes
and deliver consents after the Early Expiration Time will receive
the Total Consideration, less $50, for each $1,000 principal amount
of accepted 2026 Notes. In each case, holders of such accepted 2026
Notes will receive accrued and unpaid interest to (but excluding)
the settlement date. The Tender Offer will expire at
5:00 p.m., New York City time, on April 19, 2024, unless
extended or earlier terminated by SiriusPoint (the “Tender Offer
Expiration”).
SiriusPoint’s obligation to accept for purchase,
and to pay for, 2026 Notes validly tendered and not validly
withdrawn pursuant to the Tender Offer and the Consent Solicitation
is conditioned upon the satisfaction or, when applicable, waiver of
certain conditions, which are more fully described in the Offer to
Purchase, including, among others, a financing condition requiring
the consummation of the Debt Offering. In addition, subject to
applicable law, SiriusPoint reserves the right, in its sole
discretion, to (i) extend, terminate or withdraw the Tender Offer
or the Consent Solicitation at any time or (ii) otherwise amend the
Tender Offer or the Consent Solicitation in any respect at any time
and from time to time. SiriusPoint further reserves the right, in
its sole discretion, not to accept any tenders of 2026 Notes or
deliveries of consents with respect to the 2026 Notes.
BMO Capital Markets Corp., HSBC Securities (USA)
Inc., Jefferies LLC and J.P. Morgan Securities LLC are acting as
dealer managers for the Tender Offer and as solicitation agents for
the Consent Solicitation (the “Dealer Managers”). For questions
regarding the Tender Offer and the Consent Solicitation, the Dealer
Managers can be contacted as follows: BMO Capital Markets Corp. at
(833) 418-0762, HSBC Securities (USA) Inc. at (888) 472-2456,
Jefferies LLC at (877) 877-0696 and J.P. Morgan Securities LLC at
(866) 834-4666.
Copies of the Offer to Purchase are available to
holders of 2026 Notes from D.F. King & Co., Inc., the
information agent and the tender agent for the Tender Offer and the
Consent Solicitation. Requests for copies of the Offer to Purchase
should be directed to D.F. King & Co., Inc. toll-free at (866)
388-7535 or SPNT@dfking.com.
Following the Early Expiration Time or
settlement following the Tender Offer Expiration, as applicable,
SiriusPoint intends to deliver a notice of redemption to redeem any
2026 Notes outstanding that are not purchased pursuant to the
Tender Offer. The Company is not obligated to redeem 2026 Notes
that are not tendered and accepted in the Tender Offer, and there
can be no assurance it will do so. Statements of intent in this
press release shall not constitute a notice of redemption under the
2026 Indenture. Any such notice, if made, will only be made in
accordance with the provisions of the 2026 Indenture.
Redemption
SiriusPoint today announced that it will redeem
all $115 million aggregate principal amount of its 2025 Notes
(CUSIP No. 88428L AA0) on April 22, 2024 (the “Redemption Date”).
On the Redemption Date, SiriusPoint will pay to the registered
holders of the 2025 Notes a redemption price equal to the greater
of (i) 100% of the aggregate principal amount of the 2025 Notes to
be redeemed and (ii) an amount equal to the sum of the present
values of each of the remaining scheduled payments of principal and
interest on the 2025 Notes to be redeemed (not including any
portion of the payments of interest accrued to, but not including,
such Redemption Date), each discounted to the Redemption Date on a
semiannual basis (assuming a 360-day year consisting of twelve
30-day months) at the weekly average yield on actively traded U.S.
Treasury securities adjusted to a nominal constant maturity of one
year plus 0.50%, or 50 basis points; plus, in the case of each of
clause (i) and (ii), accrued and unpaid interest, if any, on the
principal amount of the 2025 Notes to be redeemed to, but not
including, such Redemption Date.
This press release shall not constitute an offer
to sell or the solicitation of an offer to buy nor shall there be
any sale of any securities. There shall not be any sale of the New
Notes in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
The Offer to Purchase has not been filed with
the SEC, nor have any such documents been filed with or reviewed by
any federal or state securities commission or regulatory authority
of any country. No authority has passed upon the accuracy or
adequacy of the Offer to Purchase or any related documents, and it
is unlawful and may be a criminal offense to make any
representation to the contrary. The Tender Offer and the Consent
Solicitation are being made solely on the terms and conditions set
forth in the Offer to Purchase. Under no circumstances shall this
press release constitute an offer to buy or a solicitation of an
offer to sell the 2026 Notes or any other securities of SiriusPoint
or any of its affiliates. The Tender Offer and the Consent
Solicitation are not being made to, nor will SiriusPoint accept
tenders of 2026 Notes or accept deliveries of Consents from,
holders in any jurisdiction in which the Tender Offer and the
Consent Solicitation or the acceptance thereof would not be in
compliance with the securities of blue sky laws of such
jurisdiction. This press release also is not a solicitation of
consents to the Proposed Amendment. No recommendation is made as to
whether holders should tender their 2026 Notes or deliver their
consents with respect to the 2026 Notes. Holders of 2026 Notes
should carefully read the Offer to Purchase because it contains
important information, including the various terms and conditions
of the Tender Offer and the Consent Solicitation.
This press release does not constitute a notice
of redemption of the 2025 Notes. Holders of 2025 Notes should refer
to the notice of redemption delivered to the registered holders of
the 2025 Notes by The Bank of New York Mellon, the trustee with
respect to the 2025 Notes.
Cautionary Note Regarding
Forward-Looking Statements
This press release includes “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements are subject to known
and unknown risks and uncertainties, many of which may be beyond
the Company’s control. The Company cautions you that the
forward-looking information presented in this press release is not
a guarantee of future events, and that actual events may differ
materially from those made in or suggested by the forward-looking
information contained in this press release. In addition,
forward-looking statements generally can be identified by the use
of forward-looking terminology such as “believes,” “intends,”
“seeks,” “anticipates,” “aims,” “plans,” “targets,” “estimates,”
“expects,” “assumes,” “continues,” “should,” “could,” “will,” “may”
and the negative of these or similar terms and phrases. Actual
events, results and outcomes may differ materially from the
Company’s expectations due to a variety of known and unknown risks,
uncertainties and other factors. Among the risks and uncertainties
that could cause actual results to differ from those described in
the forward-looking statements are the following: the Company’s
ability to execute on its strategic transformation, including
re-underwriting to reduce volatility and improving underwriting
performance, de-risking the Company’s investment portfolio, and
transforming the Company’s business; the impact of unpredictable
catastrophic events including uncertainties with respect to current
and future COVID-19 losses across many classes of insurance
business and the amount of insurance losses that may ultimately be
ceded to the reinsurance market, supply chain issues, labor
shortages and related increased costs, changing interest rates and
equity market volatility; inadequacy of loss and loss adjustment
expense reserves, the lack of available capital, and periods
characterized by excess underwriting capacity and unfavorable
premium rates; the performance of financial markets, impact of
inflation and interest rates, and foreign currency fluctuations;
the Company’s ability to compete successfully in the insurance and
reinsurance market and the effect of consolidation in the insurance
and reinsurance industry; technology breaches or failures,
including those resulting from a malicious cyber-attack on the
Company, the Company’s business partners or service providers; the
effects of global climate change, including increased severity and
frequency of weather-related natural disasters and catastrophes and
increased coastal flooding in many geographic areas; geopolitical
uncertainty, including the ongoing conflicts in Europe and the
Middle East; the Company’s ability to retain key senior management
and key employees; a downgrade or withdrawal of the Company’s
financial ratings; fluctuations in the Company’s results of
operations; legal restrictions on certain of SiriusPoint’s
insurance and reinsurance subsidiaries’ ability to pay dividends
and other distributions to SiriusPoint; the outcome of legal and
regulatory proceedings and regulatory constraints on the Company’s
business; reduced returns or losses in SiriusPoint’s investment
portfolio; the Company’s exposure or potential exposure to
corporate income tax in Bermuda and the E.U., U.S. federal income
and withholding taxes and the Company’s significant deferred tax
assets, which could become devalued if the Company does not
generate future taxable income or applicable corporate tax rates
are reduced; risks associated with delegating authority to third
party managing general agents; future strategic transactions such
as acquisitions, dispositions, investments, mergers or joint
ventures; SiriusPoint’s response to any acquisition proposal that
may be received from any party, including any actions that may be
considered by the Company’s Board of Directors or any committee
thereof; and other risks and factors listed under “Risk Factors” in
the Company’s most recent Annual Report on Form 10-K and other
subsequent periodic reports filed with the Securities and Exchange
Commission. All forward-looking statements speak only as of the
date made and the Company undertakes no obligation to update or
revise publicly any forward-looking statements, whether as a result
of new information, future events or otherwise.
About the Company
SiriusPoint is a global underwriter of insurance
and reinsurance providing solutions to clients and brokers around
the world. Bermuda-headquartered with offices in New York, London,
Stockholm and other locations, the Company is listed on the New
York Stock Exchange (SPNT). SiriusPoint has licenses to write
Property & Casualty and Accident & Health insurance and
reinsurance globally. SiriusPoint’s offering and distribution
capabilities are strengthened by a portfolio of strategic
partnerships with Managing General Agents and Program
Administrators within the Company’s Insurance & Services
segment.
SiriusPoint Contacts
Investor RelationsDhruv
Gahlaut, Head of Investor Relations and Chief Strategy
OfficerDhruv.gahlaut@siriuspt.com+44 7514 659 918
MediaSarah Hills,
Rein4ceSarah.hills@rein4ce.co.uk+ 44 7718882011
SiriusPoint (NYSE:SPNT)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
SiriusPoint (NYSE:SPNT)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024